The Vanguard Group Discloses Position in Spire Healthcare

The Vanguard Group, Inc. has released a Form 8.3 disclosure concerning its stake in Spire Healthcare Group plc. As of March 23, 2026, Vanguard holds 14,482,910 ordinary shares, representing 3.60% of Spire Healthcare's relevant securities. This disclosure falls under Rule 8.3 of the Takeover Code, pertinent when an entity holds interests of 1% or more in relevant securities.

The disclosure includes details of recent transactions. Vanguard purchased 4,624 shares at 1.47 GBP per unit and sold 28,224 shares at the same price. No cash-settled or stock-settled derivative transactions were reported. The document notes the absence of any indemnity arrangements, options, or derivatives agreements related to these securities.

The form provides a comprehensive overview of The Vanguard Group's current interests and recent dealings, offering essential data for stakeholders and market participants to assess their position and strategy in relation to Spire Healthcare Group plc.